Trial Summary
What is the purpose of this trial?
The investigators will recruit individuals with broadly-defined AN (n = 80) who are currently in or have recently participated in higher-level eating disorder treatment (e.g., residential, partial hospitalization/day treatment, intensive outpatient treatment). Interested participants will sign consent, complete eligibility assessments, and will be randomized to receive Positive Affect Treatment for Anorexia Nervosa (PAT-AN) or Psychoeducation and Behavioral Therapy (PBT) through teletherapy shortly following discharge from higher level of care. Participants can participate in most other forms of outpatient treatment while receiving the research intervention. Participants will engage in 24 weeks of PAT-AN or PBT starting in the first 3 months post-discharge. At each session, the investigators will complete brief measures assessing treatment acceptability, affect, and eating disorder symptoms. Participants will also complete an assessment battery of self-report, EMA, and neurocognitive measures evaluating primary outcomes (BMI; eating disorder symptoms), secondary outcomes (depression, anxiety, and suicidality), and presumed treatment mechanisms at baseline, end of treatment (EOT), and 3-month follow-up (FU). All assessments will be remotely delivered via HIPAA-compliant platforms.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, you can participate in most other forms of outpatient treatment while receiving the research intervention.
Is teletherapy treatment for anorexia nervosa safe for humans?
How is the PAT-AN treatment different from other treatments for anorexia nervosa?
PAT-AN is unique because it focuses on enhancing positive emotions and behaviors through teletherapy, which can be more accessible and convenient compared to traditional in-person therapies. This approach is different from other treatments like family-based therapy, which involves the family in the treatment process, or cognitive behavior therapy, which focuses on changing negative thought patterns.14678
Research Team
Ann Haynos, PhD
Principal Investigator
Principal Investigator
Eligibility Criteria
This trial is for adults over 18 with Anorexia Nervosa who are transitioning from intensive treatment to outpatient care or have done so within the last 3 months. They must be willing to participate in weekly assessments, speak English, and have access to a smartphone or computer. Those with medical instability, overlapping therapy content, pregnancy, substance use disorders, or primary psychotic/bipolar-I disorder cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Positive Affect Treatment for Anorexia Nervosa (PAT-AN) or Psychoeducation and Behavioral Therapy (PBT) through teletherapy for 24 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Positive Affect Treatment for Anorexia Nervosa (PAT-AN) (Behavioural Intervention)
- Psychoeducational and Behavioral Therapy (PBT) (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Commonwealth University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator